AzTrials
AzTrials

Conservative ManagementappendicitisNCT06828952

Risk Factors of Failure of Conservative Treatment in Acute Non Complicated Appendicitis

An observational study of Conservative Management, run by Ahmed Mohammed Hussein Sayed at 1 site in Egypt.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

From this study, it can be concluded that patients who meet the following criteria are more likely to fail expectant management and thus should not be considered for the NOM of uncomplicated acute appendicitis. Read more about this study

Who is it for?
Ages 16 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Conservative Management
What is being tested?
ceftriaxone and ceftriaxone 1 gm/12 hourly and IV metronidazole 500 mg/8 hourly
Type of treatment
Injection or infusion
How many people
100 participants
Where
1 siteEgypt
Study dates
22 Jun 2025to 2 Dec 2025
How long will I take part?
2 Days
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Study population: Male or female patients é diagnosis of acute appendicitis Patients with ages: from 16 to 60 years old

Who may be able to join

  • Male or female patients é diagnosis of acute appendicitis .
  • Patients with ages: from 16 to 60 years old.

Who cannot join

  • complicated AA (appendicolith, perforation, peri appendicular abscess or suspicion of a tumor).
  • inflammatory bowel disease.
  • inability to co-operate and give informed consent.
  • diffuse peritonitis.
  • antibiotic documented allergy \& allergy to contrast media .
  • Patients with serious comorbid conditions DM \& renal insufficiency, serum creatinine > 150 μmol/l .
Show all 11Show fewer
  • Pregnant \& lactating patient.
  • Patients with bleeding diathesis and those on anticoagulants.
  • Patients with advanced malignancies \& patient on immunosuppressive drugs .
  • Patients with previous appendectomy.
  • Extreme of age.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Ahmed Mohammed Hussein Sayed Ahmed Razeen, MBBCh contact

+2001099414358

Ahmed.16266245@med.aun.edu.eg

Mohamed Taher Gamal Amin Taher, MBBCh &MD &PHD contact

+2001091289046

mohamedamin022@aun.edu.eg

Egypt1 site
  • Assiut University

    Asyut, 71515

Other trials in Egypt

About this study

From this study, it can be concluded that patients who meet the following criteria are more likely to fail expectant management and thus should not be considered for the NOM of uncomplicated acute appendicitis. These include the duration of symptoms before presenting to a surgical emergency , the presence of fever within 24 hours of presenting to a surgical emergency, TLC cells/dL, CRP mg/L, appendix diameter mm, modified Alvarado score , and adult appendicitis score .

Read the detailed description

Expectant management with intravenous antibiotic therapy alone has emerged as an effective alternative to appendectomy for the treatment of uncomplicated acute appendicitis . It is important to identify patients at the onset of the disease who are likely to have successful outcomes for conservative management.

Being tested
ceftriaxone, ceftriaxone 1 gm/12 hourly and IV metronidazole 500 mg/8 hourly
Keywords
Appendicitis
Medical subject headings
Appendicitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ceftriaxoneDrug

    ceftriaxone 1 gm/12 hourly and IV metronidazole 500 mg/8 hourly

  • ceftriaxone 1 gm/12 hourly and IV metronidazole 500 mg/8 hourlyDrug

    Conservative management

Study groups in NCT06828952
Study groupRoleWhat they receive
(1) Male or female patients é diagnosis of acute appendicitis.Patients who presented with complaints of right lower quadrant pain with symptoms and signs strongly suggestive of uncomplicated acute appendicitis that was confirmed on ultrasonography, were included. The modified Alvarado score and adult appendicitis score were calculated.
Receives: Drug: ceftriaxone; Drug: ceftriaxone 1 gm/12 hourly and IV metronidazole 500 mg/8 hourly

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Risk factors of failure of conservative treatment in acute non complicated appendicitis

    modified Alvarado score and adult appendicitis score

    Measured: One year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Feb 2025
  2. Study start22 Jun 2025 (estimated)
  3. Primary completion1 Dec 2025 (estimated)
  4. Study completion2 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (estimated)
Target duration
2 Days
IDs, dates and publications
ClinicalTrials.gov ID
NCT06828952
Sponsor's protocol ID
acute appendicitis
Acronym
appendicitis
Status last verified
Dec 2024
First submitted
4 Dec 2024
Last updated
17 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Shindoh J, Niwa H, Kawai K, Ohata K, Ishihara Y, Takabayashi N, Kobayashi R, Hiramatsu T. Predictive factors for negative outcomes in initial non-operative management of suspected appendicitis. J Gastrointest Surg. 2010 Feb;14(2):309-14. doi: 10.1007/s11605-009-1094-1.

    PubMed 19936849
  • Hansson J, Khorram-Manesh A, Alwindawe A, Lundholm K. A model to select patients who may benefit from antibiotic therapy as the first line treatment of acute appendicitis at high probability. J Gastrointest Surg. 2014 May;18(5):961-7. doi: 10.1007/s11605-013-2413-0. Epub 2013 Nov 22.

    PubMed 24263678
  • Walker C, Moosavi A, Young K, Fluck M, Torres D, Widom K, Wild J. Factors Associated with Failure of Nonoperative Management for Complicated Appendicitis. Am Surg. 2019 Aug 1;85(8):865-870.

    PubMed 31560305
  • Loftus TJ, Brakenridge SC, Croft CA, Stephen Smith R, Efron PA, Moore FA, Mohr AM, Jordan JR. Successful nonoperative management of uncomplicated appendicitis: predictors and outcomes. J Surg Res. 2018 Feb;222:212-218.e2. doi: 10.1016/j.jss.2017.10.006. Epub 2017 Nov 13.

    PubMed 29146455
  • Cervellin G, Mora R, Ticinesi A, Meschi T, Comelli I, Catena F, Lippi G. Epidemiology and outcomes of acute abdominal pain in a large urban Emergency Department: retrospective analysis of 5,340 cases. Ann Transl Med. 2016 Oct;4(19):362. doi: 10.21037/atm.2016.09.10.

    PubMed 27826565

Questions about this trial

What is this clinical trial studying?

An observational study of Conservative Management, run by Ahmed Mohammed Hussein Sayed at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 17 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ahmed Mohammed Hussein Sayed Ahmed Razeen, MBBCh (+2001099414358, Ahmed.16266245@med.aun.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Risk factors of failure of conservative treatment in acute non complicated appendicitis (time frame: One year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06828952, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Feb 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in